Estrela G, Santos R, Budu A, de Arruda A, Barrera-Chimal J, Carvalho Araujo R
Biomedicines. 2023; 11(8).
PMID: 37626691
PMC: 10452634.
DOI: 10.3390/biomedicines11082194.
Zhang L, Xue S, Wu M, Dong D
Front Med (Lausanne). 2022; 9:914587.
PMID: 36117980
PMC: 9479543.
DOI: 10.3389/fmed.2022.914587.
Tsukamoto S, Wakui H, Azushima K, Yamaji T, Urate S, Suzuki T
Sci Rep. 2021; 11(1):16843.
PMID: 34413390
PMC: 8377123.
DOI: 10.1038/s41598-021-96294-8.
Kawakami R, Matsui M, Konno A, Kaneko R, Shrestha S, Shrestha S
J Pathol. 2021; 255(4):362-373.
PMID: 34370295
PMC: 9292749.
DOI: 10.1002/path.5775.
Yamato M, Kato N, Kakino A, Yamada K, Inoguchi T
Metabol Open. 2020; 7:100049.
PMID: 33015603
PMC: 7520892.
DOI: 10.1016/j.metop.2020.100049.
Germ-Free Conditions Modulate Host Purine Metabolism, Exacerbating Adenine-Induced Kidney Damage.
Mishima E, Ichijo M, Kawabe T, Kikuchi K, Akiyama Y, Toyohara T
Toxins (Basel). 2020; 12(9).
PMID: 32859011
PMC: 7551802.
DOI: 10.3390/toxins12090547.
The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment.
Kumrungsee T, Kariya T, Hashimoto K, Koyano T, Yazawa N, Hashimoto T
Sci Rep. 2019; 9(1):14101.
PMID: 31575974
PMC: 6773767.
DOI: 10.1038/s41598-019-50685-0.
Assessing the health of the nephron in acute kidney injury: biomarkers of kidney function and injury.
Menez S, Parikh C
Curr Opin Nephrol Hypertens. 2019; 28(6):560-566.
PMID: 31369422
PMC: 7391114.
DOI: 10.1097/MNH.0000000000000538.
Multiparametric magnetic resonance imaging of experimental chronic kidney disease: A quantitative correlation study with histology.
Schley G, Jordan J, Ellmann S, Rosen S, Eckardt K, Uder M
PLoS One. 2018; 13(7):e0200259.
PMID: 30011301
PMC: 6047786.
DOI: 10.1371/journal.pone.0200259.
Measurement of urinary biomarkers in a case of tubulointerstitial nephritis and uveitis syndrome during glucocorticoid treatment.
Sugiyama M
CEN Case Rep. 2018; 7(2):221-224.
PMID: 29761376
PMC: 6181902.
DOI: 10.1007/s13730-018-0330-5.
A novel approach to adenine-induced chronic kidney disease associated anemia in rodents.
Rahman A, Yamazaki D, Sufiun A, Kitada K, Hitomi H, Nakano D
PLoS One. 2018; 13(2):e0192531.
PMID: 29415057
PMC: 5802942.
DOI: 10.1371/journal.pone.0192531.
Role of artesunate in TGF‑β1‑induced renal tubular epithelial‑mesenchymal transdifferentiation in NRK‑52E cells.
Zhang Y, Li H, Zhu J, Wei T, Peng Y, Li R
Mol Med Rep. 2017; 16(6):8891-8899.
PMID: 28990102
PMC: 5779971.
DOI: 10.3892/mmr.2017.7728.
Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
Brunner H, Bennett M, Gulati G, Abulaban K, Klein-Gitelman M, Ardoin S
J Rheumatol. 2017; 44(8):1239-1248.
PMID: 28620062
PMC: 6719540.
DOI: 10.3899/jrheum.161128.
Targeting Oxygen-Sensing Prolyl Hydroxylase for Metformin-Associated Lactic Acidosis Treatment.
Oyaizu-Toramaru T, Suhara T, Hayakawa N, Nakamura T, Kubo A, Minamishima S
Mol Cell Biol. 2017; 37(16).
PMID: 28606929
PMC: 5533879.
DOI: 10.1128/MCB.00248-17.
Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease.
Tani T, Orimo H, Shimizu A, Tsuruoka S
Sci Rep. 2017; 7(1):2233.
PMID: 28533541
PMC: 5440375.
DOI: 10.1038/s41598-017-02351-6.
Pharmacologic Blockade of v1 Integrin Ameliorates Renal Failure and Fibrosis .
Chang Y, Lau W, Jo H, Tsujino K, Gewin L, Isik Reed N
J Am Soc Nephrol. 2017; 28(7):1998-2005.
PMID: 28220032
PMC: 5491273.
DOI: 10.1681/ASN.2015050585.
Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.
Hanudel M, Chua K, Rappaport M, Gabayan V, Valore E, Goltzman D
Am J Physiol Renal Physiol. 2016; 311(6):F1369-F1377.
PMID: 27733366
PMC: 5210202.
DOI: 10.1152/ajprenal.00281.2016.
Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.
Wan J, Wang Y, Cai G, Liang J, Yue C, Wang F
Oncotarget. 2016; 7(42):67748-67759.
PMID: 27589683
PMC: 5356516.
DOI: 10.18632/oncotarget.11682.
Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?.
Benzer M, Neijmann S, Gultekin N, Uluturk Tekin A
Int Urol Nephrol. 2016; 49(1):1-12.
PMID: 27550232
DOI: 10.1007/s11255-016-1389-6.
Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats.
Cao J, Wang W, Li Y, Xia J, Peng Y, Zhang Y
Int Urol Nephrol. 2016; 48(4):619-29.
PMID: 26865179
DOI: 10.1007/s11255-016-1232-0.